Ensuring Access to Psychedelic-Assisted Therapy in Rural Communities.
Psychedelic medicine (New Rochelle, N.Y.) June 1, 2025 Olivia M Dhaliwal, Lukas Bobak, Brian S. Barnett
With several classical psychedelics being designated as breakthrough therapies and the recent review of a New Drug Application for 3,4-Methylenedioxymethamphetamine in the treatment of posttraumatic stress disorder, the likelihood of psychedelic medication becoming approved for clinical use in the United States is high. Psychedelic-assisted therapy (PAT) may have a high demand in rural America,...